7733 On Other Exchanges
7733 is not on other exchanges.

olympus corp (7733) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OLYMPUS CORP (7733)

Related News

No related news articles were found.

olympus corp (7733) Related Businessweek News

View More BusinessWeek News

olympus corp (7733) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment offers endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment provides upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, x-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment provides biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

33,336 Employees
Last Reported Date: 06/28/16
Founded in 1919

olympus corp (7733) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥106.4M
Compensation as of Fiscal Year 2016.

olympus corp (7733) Key Developments

Olympus Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Revises Consolidated Earnings Guidance for the Second Half and Year Ending March 31, 2017; Provides Dividend Guidance for the Year Ending March 31, 2017

Olympus Corporation reported consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, on consolidated basis, the company reported net sales of JPY 168,438 million compared to JPY 187,572 million a year ago. Operating income was JPY 10,808 million compared to JPY 17,165 million a year ago. Ordinary income was JPY 8,313 million compared to JPY 16,679 million a year ago. Net income attributable to owners of the parent was JPY 8,530 million compared to JPY 16,734 million a year ago. Net income was JPY 8,553 million compared to JPY 16,742 million a year ago. Net income per share was JPY 24.92 compared to JPY 48.88 a year ago. Income before provision for income taxes was JPY 7,336 million compared to JPY 14,258 million a year ago. The company revised consolidated earnings guidance for the second half and year ending March 31, 2017. For the second half, the company expects net sales of JPY 366,000 million against JPY 380,000 million expected previously. Operating income is expected to be JPY 29,000 million against JPY 37,000 million expected previously. Ordinary income is expected to be JPY 25,000 million against JPY 32,000 million expected previously. Net income attributable to shareholders of the parent is expected to be JPY 20,000 million or JPY 58.44 per share against JPY 27,000 million or JPY 81.81 per share expected previously. For the full year, the company expects net sales of JPY 775,000 million against JPY 800,000 million expected previously. Operating income is expected to be JPY 77,000 million against JPY 90,000 million expected previously. Ordinary income is expected to be JPY 67,000 million against JPY 80,000 million expected previously. Net income attributable to shareholders of the parent is expected to be JPY 57,000 million or JPY 166.55 per share against JPY 65,000 million or JPY 189.93 per share expected previously. The company provided dividend guidance for the year ending March 31, 2017. For the year, the company expects to pay a dividend of JPY 28.00 against JPY 17.00 per share paid a year ago.

Olympus Corporation Opens New Thai-Training and Education Center in Bangkok, Thailand

Olympus Corporation announced that it has opened its new Thai-Training and Education Center, or T-TEC, in Bangkok, Thailand. T-TEC provides a venue for delivering endoscopy and surgical training and education to medical practitioners in Southeast Asia. T-TEC is established as a venue for delivering endoscopy training and education to medical practitioners to help strengthen medical practice associated with gastrointestinal and surgical endoscopes in the nations of Southeast Asia, including awareness of endoscopes and diagnosis and treatment techniques. Being easily accessible from elsewhere in Southeast Asia, the site in Thailand was chosen with the aim of encouraging use by a greater number of medical practitioners. In addition to training for nurses and technicians as well as surgeons, T-TEC is also intended as a venue for Olympus staff training. The design of the T-TEC building was inspired by Mount Olympus from which the company took its name. The aim is for it to serve as a "base camp" that will provide both venue and opportunities for high-quality training to medical practitioners as they seek to continually improve their skills.

Olympus Corporation to Report Q1, 2017 Results on Aug 03, 2016

Olympus Corporation announced that they will report Q1, 2017 results on Aug 03, 2016


The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

7733 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7733.
View Industry Companies

Industry Analysis


Industry Average

Valuation 7733 Industry Range
Price/Earnings 22.1x
Price/Sales 1.5x
Price/Book 3.4x
Price/Cash Flow 12.7x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.